JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 8 December 2006. doi:10.1136/jcp.2006.044222
Journal of Clinical Pathology 2007;60:1092-1097
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcp.2006.044222v1
60/10/1092    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Atayar, C.
Right arrow Articles by Poppema, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Atayar, C.
Right arrow Articles by Poppema, S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Hodgkin's Disease

ORIGINAL ARTICLES

Hodgkin’s lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments

Çigdem Atayar1, Anke van den Berg1, Tjasso Blokzijl1, Marcel Boot1, Randy D Gascoyne2, Lydia Visser1, Sibrand Poppema1

1 Department of Pathology & Laboratory Medicine, University of Groningen and University Medical Centre Groningen, The Netherlands
2 Department of Pathology, University of British Columbia and British Columbia Cancer Agency, Vancouver, BC, Canada

Correspondence to:
Professor Sibrand Poppema, Department of Pathology & Laboratory Medicine, University Medical Centre Groningen, Hanzeplein 1, PO Box 30.001, 9700 RB Groningen The Netherlands; s.poppema{at}rvb.umcg.nl

Background: Hodgkin’s lymphoma (HL) is characterised by an ineffective immune response that is predominantly mediated by CD4+ T-cells.

Aims: To analyse the expression of the key regulatory T-cell transcription factors (TFs) in the T-cells of HL involved tissues in order to assess the nature of the TH immune response in HL.

Methods and results: By immunohistochemistry, GATA3 was strongly and T-bet exclusively expressed in a subset of interfollicular lymphocytes in the reactive lymphoid tissues. In classical HL (CHL), which is generally located in the interfollicular zones, a predominance of T-bet+ T-cells and lesser amounts of GATA3+ and c-Maf+ T-cells was found, concordant with the pattern of the normal interfollicular compartment. In reactive lymphoid tissues, c-Maf was observed mostly in T-lymphocytes within the germinal centres (GCs). Nodular lymphocyte predominance type of Hodgkin’s lymphoma (NLPHL) and progressively transformed germinal centres cases, showed a majority of c-Maf+ T-cells, consistent with the pattern in normal GCs. NLPHL cases uniformly showed c-Maf+/CD57+ T-cell rosettes around the neoplastic cells; these rosettes were absent in "paragranuloma-type" T-cell/histiocyte rich B-cell lymphoma.

Conclusions: T-cell TF expression profiles of the reactive T-cells in both subtypes of HL are in accordance with the expression profile observed in the distinct lymphoid compartments.


Abbreviations: CHL, classical Hodgkin’s lymphoma; GC, germinal centre; HL, Hodgkin’s lymphoma; HRBCL, histiocyte rich B-cell lymphoma; HRS, Hodgkin and Reed–Sternberg; L&H, lymphocytic and/or histiocytic; NLPHL, nodular lymphocyte predominance type of Hodgkin’s lymphoma; PTGC, progressively transformed germinal centre; TF, transcription factor; TH, T-helper

Keywords: Hodgkin’s lymphoma; nodular lymphocyte predominance type of Hodgkin’s lymphoma; progressive transformation of germinal centres; T-cell transcription factors; T-helper cells







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.